ALMR
Alamar Biosciences, Inc. Common Stock
NASDAQ: ALMR · HEALTHCARE · MEDICAL DEVICES
$27.89
+0.43% today
Updated 2026-09-11
Market cap
$2.01B
P/E ratio
—
P/S ratio
20.01x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$17 – $39
Volume
0.3M
Alamar Biosciences, Inc. Common Stock (ALMR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$27.89
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $0.0B | $0.1B |
| EPS | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -49.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.